Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

D E Shaw’s Top Mid-Cap Stock Picks ~ Verisign, Inc. (VRSN), Allison Transmission Holdings Inc (ALSN), Spirit AeroSystems Holdings, Inc. (SPR)

Page 1 of 2

David E. Shaw gained popularity through his exploitation of inefficiencies in the financial market with the help of computational algorithms and a strong computer network, with Fortune magazine once calling his fund “”the most intriguing and mysterious force on Wall Street.” In its recent 13F filing with the SEC, D E Shaw, the fund founded by David Shaw, who remains the Chief Scientist of D E Shaw Research, reported an equity portfolio of $65.29 billion as of the reporting period of March 31. The fund is primarily invested in the technology and consumer discretionary sectors. While its primary stock picks include a put position in Apple Inc. (NASDAQ:AAPL) and a long position in Phillips 66 (NYSE:PSX), D E Shaw has investments in numerous mid-cap stocks, which we will discuss in this article. Some of its top mid-cap stock holdings include Verisign, Inc. (NASDAQ:VRSN), Allison Transmission Holdings Inc (NYSE:ALSN) and Spirit AeroSystems Holdings, Inc. (NYSE:SPR).

David E. Shaw Vertex Pharmaceutical

Hedge funds and other big money managers like D E Shaw tend to have the largest amounts of their capital invested in large and mega-cap stocks like Apple Inc. (NASDAQ:AAPL) because these companies allow for much greater capital allocation. That’s why if we take a look at the most popular stocks among funds, we won’t find any mid- or small-cap stocks there. However, our backtests of hedge funds’ equity portfolios between 1999 and 2012 revealed that the 50 most popular stocks among hedge funds underperformed the market by seven basis points per month, showing that their most popular picks and the ones that received the bulk of their capital were not actually their best picks. On the other hand, their top small-cap picks performed considerably better, outperforming the market by 95 basis points per month. This was confirmed through backtesting and in forward tests of our small-cap strategy since August 2012. The strategy, which involves imitating the 15 most popular small-cap picks among hedge funds has provided gains of more than 144%, beating the broader market by over 84 percentage points through the middle of May (see the details).

With 4.77 million shares valued at $319.63 million, Verisign, Inc. (NASDAQ:VRSN) is the largest mid-cap stock investment of D E Shaw. The firm has increased its stake in the domain name provider by 20% during the first quarter. Verisign, Inc. (NASDAQ:VRSN) has a market cap of $7.51 billion along with a current P/E ratio of 25.40. Verisign, Inc. (NASDAQ:VRSN) is also one of the top mid-cap stock picks of Warren Buffett, with the investing legend owning 12.99 million shares of the company. Renaissance Technologies, another quant fund, and Makaira Partners are among the other major stock holders of the company.

D E Shaw is the second-largest shareholder of Allison Transmission Holdings Inc (NYSE:ALSN) in our database with 9.40 million shares valued at $300.25 million. The fund trimmed its investment in the automatic-transmission manufacturer by 4% during the first quarter. Allison Transmission Holdings Inc (NYSE:ALSN) has a market cap of $5.66 billion and its shares trade at $31.53 with a P/E ratio of 23.28. ValueAct Capital and Gates Capital Management hold major positions in Allison Transmission Holdings Inc (NYSE:ALSN).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!